MétaCan
Menu
← Back to cohort

The utility of a modified frailty index in predicting chemotherapy toxicity, response and survival for older patients (pts) with advanced pancreatic cancer receiving first-line palliative chemotherapy: A single institution experience.

2018· article· en· W2889823387 on OpenAlexaffabout
Han‐Bo Zhang, David E. Dawe, Robert Kudlovich, Christina Kim

Bibliographic record

VenueJournal of Clinical Oncology · 2018
Typearticle
Languageen
FieldMedicine
TopicFrailty in Older Adults
Canadian institutionsUniversity of WinnipegCancerCare ManitobaUniversity of Manitoba
Fundersnot available
KeywordsMedicineFOLFIRINOXInternal medicineGemcitabineIrinotecanOxaliplatinChemotherapyPancreatic cancerPerformance statusCancerOncologySurgeryColorectal cancer

Abstract

fetched live from OpenAlex

e22030 Background: Advanced pancreatic cancer (APC) primarily occurs in pts ≥ 65 years old. Chemotherapy decisions are challenging in this group. The Modified Frailty Index (mFI) is an 11-component measure of frailty which has been validated in surgical fields, but yet to be tested in older pts with APC receiving first-line palliative chemotherapy, with 5-fluorouracil, irinotecan and oxaliplatin (FOLFIRINOX), nab-paclitaxel and gemcitabine (NG), or gemcitabine alone (GEM). We sought to assess the correlation between mFI scores for older chemotherapy-treated APC pts with toxicity, response and survival. Methods: Pts ≥65 diagnosed with APC from 2011-2016 and treated with palliative chemotherapy at CancerCare Manitoba were identified from the Manitoba Cancer Registry. A retrospective analysis was performed to determine mFI scores for all pts based on 11 components (Nonindependent functional status, diabetes, chronic obstructive pulmonary disease, myocardial infarction, coronary artery disease, hypertension, congestive heart failure, peripheral vascular disease, transient ischemic attack, stroke, and impaired sensorium). Demographics, toxicity, response and survival were compared by mFI score. Results: 87 pts received chemotherapy, of which 20, 28, 25 and 14 had mFI scores of 0, 1, 2, and ≥ 3 respectively. Median age by mFI score was 69 (65-88), 73(65-80), 71(65-84) and 71(66-78), respectively. 52 pts received FOLFIRINOX (14 mFI 0, 19 mFI 1, 12 mFI 2, 7 mFI ≥ 3); 24 pts received NG and 14 pts received GEM. Neutropenia was similar (55%, 67.9%, 60%, 57.1% respectively), and there was no difference in other toxicities across mFI scores. Response rates were similar across mFI scores (p = 0.695), as were 6 and 12-month survival (p = 0.981 and p = 0.430, respectively). Conclusions: In elderly treated with chemotherapy for APC, retrospective mFI did not correlate with chemotherapy toxicity, response or survival. This may be due to small sample and the rigorous selection of older pts receiving chemotherapy for APC.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.011
Threshold uncertainty score0.021

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.003
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.106
GPT teacher head0.440
Teacher spread0.334 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2018
Admission routes2
Has abstractyes

Explore more

Same venueJournal of Clinical Oncology→Same topicFrailty in Older Adults→French-language works237,207→